HETEROCYCLIC COMPOUNDS AND METHODS OF USE

In one aspect, the present invention provides for a compound of Formula I in which the variable X1a, X1b, X1c, X1d, Q, A, R1, B, L, E, and the subscripts m and n have the meanings as described herein. In another aspect, the present invention provides for pharmaceutical compositions comprising compou...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Hauptverfasser: SMITH, BRIAN, JOHN, TAO, ZHI-FU, NIKOLAKOPOULOS, GEORGE, BAELL, JONATHAN, BAYLDON, SOUERS, ANDREW, J, COLMAN, PETER, NDUBAKU, CHUDI, PETROS, ANDREW, M, WANG, XILU, DUDLEY, DANETTE, A, CZABOTAR, PETER, ELMORE, STEVEN, W, HASVOLD, LISA, A, LESSENE, GUILLAUME, LAURENT, BUI, CHINH, THIEN, WANG, LE, SLEEBS, BRAD, EDMUND, WATSON, KEITH, GEOFFREY, DESHAYES, KURT, FAIRBROTHER, WAYNE, J, FLYGARE, JOHN, A
Format: Patent
Sprache:eng ; fre ; ger
Schlagworte:
Online-Zugang:Volltext bestellen
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
Beschreibung
Zusammenfassung:In one aspect, the present invention provides for a compound of Formula I in which the variable X1a, X1b, X1c, X1d, Q, A, R1, B, L, E, and the subscripts m and n have the meanings as described herein. In another aspect, the present invention provides for pharmaceutical compositions comprising compounds of Formula I as well as methods for using compounds of Formula I for the treatment of diseases and conditions (e.g., cancer, thrombocythemia, etc) characterized by the expression or over-expression of Bcl-2 anti-apoptotic proteins, e.g., of anti-apoptotic Bcl-xL proteins.